Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Struthers

Showing results (21-30 of 306) with videos related to

Pageof 31
Sort By:
European Heart Journal|September 7, 2000
N-terminal proBNP--the most cost effective way to identify post myocardial infarction left ventriular dysfunction?A D Struthers
Fundamental & Clinical Pharmacology|February 24, 2001
Pathophysiology of aldosterone and its antagonistsA D Struthers
Clinical and Experimental Pharmacology & Physiology|March 10, 2001
Careful screening to target interventions to prevent sudden cardiac deathA D Struthers
Pharmacology & Therapeutics|January 1, 1992
The clinical pharmacology of angiotensin converting enzyme inhibitors in chronic heart failureA D Struthers
Heart (British Cardiac Society)|October 9, 1998
Angiotensin II receptor antagonists for heart failureA D Struthers
Journal of Human Hypertension|June 1, 1995
Mineralocorticoid receptor blockade in chronic heart failureA D Struthers
European Journal of Clinical Pharmacology|January 1, 1988
Frusemide pretreatment blunts the inhibition of renal tubular sodium reabsorption by ANF in manJ McMurray, A D Struthers
Clinical Science (London, England : 1979)|April 1, 1988
Effects of angiotensin II and atrial natriuretic peptide alone and in combination on urinary water and electrolyte excretion in manJ McMurray, A D Struthers
BMJ (Clinical Research Ed.)|August 19, 2000
Risk assessment of left ventricular systolic dysfunction in primary care. Drug treatment might be contaminating factorR Kelly, A D Struthers
QJM : Monthly Journal of the Association of Physicians|August 10, 2005
B-type natriuretic peptide: a simple new test to identify coronary artery disease?A D Struthers, J Davies
Pageof 31

Showing results (21-30 of 306) with videos related to

Sort By:
Pageof 31
European Heart Journal|September 7, 2000
N-terminal proBNP--the most cost effective way to identify post myocardial infarction left ventriular dysfunction?A D Struthers
Fundamental & Clinical Pharmacology|February 24, 2001
Pathophysiology of aldosterone and its antagonistsA D Struthers
Clinical and Experimental Pharmacology & Physiology|March 10, 2001
Careful screening to target interventions to prevent sudden cardiac deathA D Struthers
Pharmacology & Therapeutics|January 1, 1992
The clinical pharmacology of angiotensin converting enzyme inhibitors in chronic heart failureA D Struthers
Heart (British Cardiac Society)|October 9, 1998
Angiotensin II receptor antagonists for heart failureA D Struthers
Journal of Human Hypertension|June 1, 1995
Mineralocorticoid receptor blockade in chronic heart failureA D Struthers
European Journal of Clinical Pharmacology|January 1, 1988
Frusemide pretreatment blunts the inhibition of renal tubular sodium reabsorption by ANF in manJ McMurray, A D Struthers
Clinical Science (London, England : 1979)|April 1, 1988
Effects of angiotensin II and atrial natriuretic peptide alone and in combination on urinary water and electrolyte excretion in manJ McMurray, A D Struthers
BMJ (Clinical Research Ed.)|August 19, 2000
Risk assessment of left ventricular systolic dysfunction in primary care. Drug treatment might be contaminating factorR Kelly, A D Struthers
QJM : Monthly Journal of the Association of Physicians|August 10, 2005
B-type natriuretic peptide: a simple new test to identify coronary artery disease?A D Struthers, J Davies
Pageof 31